Price Band
₹86 - ₹91
Lot Size
164
Issue Size
₹121.03 Cr
GMP
N/A
Subscription
7.12x
Analyzing...
IPO Schedule
1
Open
26 Aug 2025
2
Close
29 Aug 2025
3
Allotment
1 Sept 2025
4
Listing
3 Sept 2025
About Anlon Healthcare Ltd
Anlon Healthcare Ltd is a pharmaceutical company focused on manufacturing and marketing a diverse range of pharmaceutical products. They operate primarily in the domestic market, catering to various therapeutic segments.
Key Strengths
- High Return on Equity (ROE) of 40.45% indicates strong profitability and efficient use of shareholder equity.
- Reasonable P/E ratio of 17.67 suggests the company might be undervalued compared to its earnings.
- Established presence in the pharmaceutical market with a diverse product portfolio.
- Experienced management team with a proven track record.
- Potential for growth in the expanding healthcare sector.
Risk Factors
- •Dependence on regulatory approvals and changes in government policies.
- •Competition from established players and generic drug manufacturers.
- •Fluctuations in raw material prices and supply chain disruptions.
Valuation Analysis
The IPO appears reasonably priced considering the company's strong ROE and P/E ratio, but investors should carefully assess the inherent risks associated with the pharmaceutical industry and overall market conditions.
IPO Details
ExchangeBSE
SegmentMAINBOARD
ISININE0Y8W01017
NSE SymbolAHCL
Face Value₹10
Lot Size164
Issue Size₹121.03 Cr
Key Metrics
ROE40.45%
ROCE21.93%
P/E Ratio17.67
Industry P/E20
EPS5.15
PAT Margin17.06%
Debt/Equity0.73
Growth & Quality
ProfitableYes ✓
Subscription
Total1.69x
Documents
Registrar
KARVY
Key Dates
Open Date26 Aug 2025
Close Date29 Aug 2025
Allotment1 Sept 2025
Listing3 Sept 2025